Chad Cook, a lawyer in our Mass Torts Section, is currently responsible for a number of cases including Fosamax,Heparin, Reglan and Zithromax litigation. He also assists in investigating new... Read more
On July 8 the United States District Court in West Virginia began the first bellwether trial in the C.R. Bard, Inc. Multidistrict Litigation (MDL). Bard is a manufacturer of transvaginal mes... Read more
Thousands of women continue to experiencing life-altering and painful adverse events as a result of the implantation of transvaginal mesh. Many women have not yet sought medical or legal adv... Read more
A fifth multidistrict litigation (MDL) has been formed in the Southern District of West Virginia for transvaginal mesh products manufactured by Coloplast Corporation. Judge Joseph R. Goodwin... Read more
In ongoing mass tort litigation over vaginal mesh implants, new bellwether trial dates have been set for cases over the Avaulta mesh product, manufactured by C.R. Bard. The development comes... Read more
Chad Cook, a lawyer in our Mass Torts Section, has been heavily involved in the Fosamax, Heparin, Reglan and Zithromax litigation. Chad also assists in investigating new drugs and medical de... Read more
Chad Cook, a lawyer in our firm’s Mass Torts Section, has been selected to help direct litigation related to femur fractures caused by the osteoporosis medication Fosamax®. Chad is one of 11... Read more
GlaxoSmithKline (GSK), the manufacturer of Paxil, has agreed to settlements in nearly 200 individual cases alleging that the antidepressant caused birth defects. Most of the cases alleged th... Read more
The second trial in the Fosamax Multi-district Litigation, located in the Southern District of New York, began on April 19th. The Plaintiff in the case is Louise Maley from Muncie, Indiana.... Read more
We recently reported about a $13 million verdict in Florida against the makers of the Fentanyl pain patch. Shortly thereafter, Ortho-McNeil-Janssen Pharmaceuticals, Inc., a subsidiary of Joh... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.